Chairs: Antonella Conte (Rome, Italy) | Marco Salvetti, (Rome, Italy) | Massimiliano di Filippo, (Perugia, Italy) | Diego Centonze, (Rome, Italy)
10:15-10:30 Multiple sclerosis fluid biomarker signature across a cohort with deeply phenotyped cognitive function Anna Lidia Wojdala, Neurochemistry Laboratory, Dept of Laboratory Medicine, VUmc Amsterdam, Alamar Biosciences
10:30-11:00 Immune network evolution Janneke Van Winderden, Senior Global Medical Director, Sanofi Specialty Care
11:00-11:30 Innovation by Convergence: Neuroimmunology within a Multi-Frontier Ecosystem Silvia Rossi, Medical Director Italy, Argenx
11:30-12:00 Assessing fenebrutinib across the MS continuum: results from phase 3 studies in relapsing and primary progressive MS H. Christian van Büdingen, MD, FAAN, Vice President and Global Head MS and Neuroimmunology, Roche